A-share capital map Haikou: 27 companies are listed, with a market value of nearly 300 billion Post date May 17, 2022 — 16:01 Post Lock Read More The latest shareholder number of 5 ChiNext stocks fell by more than 5%_Oriental Fortune Net Post date May 17, 2022 — 10:25 Post Lock Read More The latest list of the number of shareholders of the GEM stocks declines_Oriental Fortune Net Post date May 16, 2022 — 11:20 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest shareholder number of 5 ChiNext stocks fell by more than 5%_Oriental Fortune Net Post date May 17, 2022 — 10:25 Post Lock Read More The latest list of the number of shareholders of the GEM stocks declines_Oriental Fortune Net Post date May 16, 2022 — 11:20 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest list of the number of shareholders of the GEM stocks declines_Oriental Fortune Net Post date May 16, 2022 — 11:20 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest chip change in ChiNext stocks: the number of 5 shareholders has dropped by more than 5%- CFi.CN Zhongcai Network Post date May 13, 2022 — 12:54 Post Lock Read More The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The latest chip change in GEM stocks: the number of 5 shareholders has dropped by more than 5%_Oriental Fortune Network Post date May 13, 2022 — 12:38 Post Lock Read More List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
List of the latest ChiNext concentrated stocks (with shares) _ Oriental Fortune Net Post date May 12, 2022 — 12:54 Post Lock Read More GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
GF Jurui Mixed A Net Worth Up 3.30% Post date May 12, 2022 — 09:11 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Puli Pharma (300630): Share Repurchase Progress- CFi.CN China Financial Network Post date May 5, 2022 — 19:45 Post Lock Read More Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Puli Pharmaceutical: The cumulative repurchase of about 320,000 shares accounted for 0.07% _ Oriental Fortune Net Post date May 5, 2022 — 19:32 Post Lock Read More Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Pharmaceutical API Summary: Supply Chain ROE Improves Manufacturing End Product Upgrade Post date May 1, 2022 — 15:22 Post Lock Read More Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Puli Pharma (300630): First repurchase of company shares CFi.CN China Financial Network Post date April 27, 2022 — 18:36 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Penghua Zengrui Mixed (LOF) Net Worth Down 3.24% Post date April 27, 2022 — 07:25 Post Lock Read More Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Puli Pharmaceutical (300630.SZ) 2021 net profit rose 2.25% to 417 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Puli Pharmaceutical (300630.SZ): Net profit in the first quarter rose 33.44% to 162 million yuan Post date April 26, 2022 — 16:16 Post Lock Read More Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Sinolink Securities maintains the overweight rating of Puli Pharmaceutical: the rapid growth of preparations overseas and the steady progress of innovative business – yqqlm Post date April 26, 2022 — 15:16 Post Lock Read More
Caishen.CoCaishen.Co